Market Insights and Analysis: Global Biologics Market Overview and Projections (2024-2030)
The Global Biologics Market size is valued at USD 412 billion in 2024 and is projected to grow at a CAGR of around 8.25% during the forecast period, i.e., 2024-30. The surging expenditures in healthcare, a hike in the sedentary lifestyles of individuals, and the rising number of chronic disease patients are some of the highlighting aspects promoting the industry growth.
Top leading companies in the Global Biologics Market includes:
Bristol-Myers Squibb, Pfizer, Sanofi, Janssen Biotech, Inc., Bayer AG, Merck & Co., Amgen Inc., Abbott GmbH, Novartis, AstraZeneca Plc, GlaxoSmithKline Biologicals, Moderna, Inc., Ferring Pharmaceuticals Inc., Aimmune Therapeutics, Inc., F. Hoffman La Roche, and Others.
Global Biologics Market Trend:
Rising Demand for Personalized Medicine Augmenting the Biologics Market Growth – In recent years, there has been a significant increase in the demand for personalized medicines among patients and healthcare professionals across the globe, as they meet the specific needs of an individual. Hence, as biologics can be modified and engineered to fit these requirements, it has been used largely by pharmaceutical companies for the development of personalized medicines, which have been offering more effective & patient-centric treatment options. Thus, the demand for personalized medicine has emerged as a new trend in the Global Biologics Market in recent years.
Moreover, in addition to the development of precision medicines, biologics also play a major role in the identification and development of diagnostic tools such as biomarkers, which allow disease diagnosis. Consequently, with advancements in the usage of biologics for the development of diagnostic methods and precision medicines, it is anticipated to contribute to the market growth in the coming years as well.
Access the detailed PDF Sample report- https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html
Report Segmentation:
The market is categorized into the following segments in the report:
By Therapeutic Application
-Oncology- Market Size & Forecast 2019-2030, (USD Million)
-Infectious Disease- Market Size & Forecast 2019-2030, (USD Million)
-Autoimmune Disease- Market Size & Forecast 2019-2030, (USD Million)
-Diabetes- Market Size & Forecast 2019-2030, (USD Million)
-Cardiovascular Diseases- Market Size & Forecast 2019-2030, (USD Million)
-Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2019-2030, (USD Million)
By Drug Class
-Recombinant Proteins- Market Size & Forecast 2019-2030, (USD Million)
-Hormones- Market Size & Forecast 2019-2030, (USD Million)
-Cytokines- Market Size & Forecast 2019-2030, (USD Million)
-Monoclonal Antibodies- Market Size & Forecast 2019-2030, (USD Million)
-Blood & Blood Components- Market Size & Forecast 2019-2030, (USD Million)
-Cellular & Gene Therapy- Market Size & Forecast 2019-2030, (USD Million)
-Vaccines- Market Size & Forecast 2019-2030, (USD Million)
-Others- Market Size & Forecast 2019-2030, (USD Million)
By Source
-Microbes- Market Size & Forecast 2019-2030, (USD Million)
-Humans- Market Size & Forecast 2019-2030, (USD Million)
-Others (Rodents, Plants, etc.)- Market Size & Forecast 2019-2030, (USD Million).
Explore Our Comprehensive Study Reports – https://www.marknteladvisors.com/research-library/global-biologics-market.html
Global Biologics Market Geographic Reach:
The Geographic Reach of the Global Biologics Market evaluates the spread and significance of Global Biologics market consumption across different regions/country, emphasizing areas with the largest market size and the most promising growth potential.
· North America: USA, Canada, Mexico
· Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
· Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
· South America: Brazil, Rest of South America
· Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of the Middle East & Africa.
Note: If you require specific information not covered in the current report, we can provide it through customized option
Why choose Us?
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
